Financial Performance - Consolidated net income applicable to common shareholders increased by $2.56 billion to $3.72 billion in Q3 2025, and increased by $3.71 billion to $6.36 billion in the first nine months of 2025 compared to the same periods in 2024, primarily due to higher underwriting income and gains on dispositions [239]. - Total revenues increased by 3.8% to $17.26 billion in Q3 2025 and increased by 5.8% to $50.34 billion in the first nine months of 2025 compared to the same periods in 2024, driven by higher auto and homeowners insurance policies in force and premium rate increases [242]. - Net investment income rose by $166 million to $949 million in Q3 2025 and increased by $298 million to $2.56 billion in the first nine months of 2025 compared to the same periods in 2024, primarily due to improved market-based and performance-based investment results [243]. - Underwriting income for Allstate Protection was $3.04 billion in Q3 2025, up from $555 million in Q3 2024, and totaled $4.69 billion in the first nine months of 2025 compared to $1.32 billion in the same period of 2024 [250]. - Premiums written increased by 6.3% to $15.63 billion in Q3 2025 and increased by 6.7% to $44.97 billion in the first nine months of 2025 compared to the same periods in 2024, reflecting higher auto and homeowners insurance policies in force [251]. Cost Management - Total costs and expenses decreased to $13.16 billion in Q3 2025 from $15.21 billion in Q3 2024, and totaled $43.71 billion in the first nine months of 2025 compared to $44.29 billion in the same period of 2024 [249]. - The expense ratio for Q3 2025 was 21.8%, an increase of 0.3 percentage points from 21.5% in Q3 2024 [298]. - Total underwriting expenses rose by $224 million or 7.6% to $3,173 million in Q3 2025 compared to Q3 2024 [298]. Investment Performance - Total investments reached $82.33 billion as of September 30, 2025, up from $72.61 billion as of December 31, 2024, primarily due to operating and investment cash flows [314]. - Fixed income securities totaled $57.19 billion as of September 30, 2025, an increase from $52.75 billion as of December 31, 2024 [320]. - The company reported a net investment income of $2,557 million for the first nine months of 2025, an increase of 13.2% or $298 million compared to the same period in 2024 [337]. - The company’s total equity securities reached a fair value of $5,338 million as of September 30, 2025, up from $4,463 million at the end of 2024 [336]. Underwriting and Claims - The loss ratio for the third quarter of 2025 improved to 58.3%, compared to 74.9% in the same quarter of 2024, indicating better claims management [262]. - The combined ratio for the third quarter of 2025 was 80.1%, a notable improvement from 96.4% in the third quarter of 2024, reflecting enhanced underwriting performance [262]. - Catastrophe losses for the third quarter of 2025 were $558 million, down from $1.70 billion in the same period of 2024, contributing to improved underwriting results [264]. - The auto loss ratio decreased by 11.3 points to 60.6% in Q3 2025 compared to Q3 2024, driven by increased earned premiums and lower claim frequency [279]. Shareholder Returns - The company repurchased 4.0 million common shares for $805 million during the first nine months of 2025, representing 1.5% of total common shares outstanding at the end of 2024 [350]. - The company paid dividends totaling $773 million in the first nine months of 2025, with a maximum estimated dividend capacity of $3.95 billion through February 2026 [359]. Risk Management - Key risks include actual claim costs exceeding reserves and unexpected increases in claim frequency or severity [364]. - The company emphasizes the importance of managing risks related to cybersecurity and information security controls [364]. - Regulatory limitations on rate increases and underwriting standards could affect financial performance [364]. - The availability and cost of reinsurance are critical factors for the company's operations [364].

Financial Performance - For the three months ended September 30, 2025, the company generated revenue of $618 million, net income of $106 million, and Adjusted EBITDA of $195 million, compared to $540 million, $100 million, and $165 million for the same period in 2024[102]. - Revenue for the three months ended September 30, 2025, was $618 million, a 14% increase from $540 million in the same period of 2024[124]. - Net income for the three months ended September 30, 2025, was $106 million, a 5% increase from $100 million in 2024[124]. - Adjusted EBITDA for the three months ended September 30, 2025, was $195 million, up 18% from $165 million in the same period of 2024[144]. - For the nine months ended September 30, 2025, net income increased to $253 million, compared to $226 million for the same period in 2024, reflecting a 12% growth[146]. Revenue Sources - For the nine months ended September 30, 2025, total operating revenue included 76% from existing customer renewals, 7% from new home warranty sales related to existing home transactions, and 9% from direct-to-consumer sales[102]. - The company’s revenue is primarily derived from home warranty contracts, which are typically one year in duration[115]. - Renewal revenue increased by $40 million (9%) to $461 million for the three months ended September 30, 2025, compared to $422 million in 2024[126]. Customer Metrics - The company had approximately 2.1 million active home warranties across all brands in the United States as of September 30, 2025[101]. - The number of home warranties grew to 2.11 million as of September 30, 2025, an 8% increase from 1.95 million in 2024[130]. - The customer retention rate and the number of home warranties are critical metrics for measuring operating performance[121]. - The company reported a customer retention rate of 79.4% as of September 30, 2025, an increase from 77.7% in 2024[130]. Costs and Expenses - Selling and administrative expenses rose to $174 million for the three months ended September 30, 2025, up from $154 million in 2024, reflecting costs associated with the 2-10 HBW Acquisition[135]. - Interest expense increased to $20 million for the three months ended September 30, 2025, compared to $10 million in 2024, driven by a higher debt balance from the 2-10 HBW Acquisition[140]. - Cost of services rendered was $264 million for the three months ended September 30, 2025, up from $235 million in 2024, reflecting inflationary cost pressures[132]. Strategic Acquisitions - The company anticipates continued strategic acquisition opportunities in the fragmented home services industry, having recently acquired 2-10 HBW to expand its customer base and revenue[112]. - The acquisition of 2-10 HBW on December 19, 2024, represented approximately 42% of the company's consolidated total assets and 9% of its consolidated total revenues as of September 30, 2025[172]. Cash Flow and Capital Management - Cash and cash equivalents totaled $563 million as of September 30, 2025, compared to $421 million as of December 31, 2024[150]. - Net cash provided from operating activities for the nine months ended September 30, 2025, was $315 million, an increase of 49% from $212 million in 2024[160]. - Free Cash Flow for the nine months ended September 30, 2025, was $296 million, compared to $181 million for the same period in 2024[167]. - Net cash used for financing activities was $210 million for the nine months ended September 30, 2025, compared to $131 million in 2024[165]. - The company expects capital expenditures for the full year 2025 to be approximately $30 million, focusing on recurring capital needs and technology projects[163]. Share Repurchase Program - The company repurchased 4,545,461 shares at an aggregate cost of $234 million under its share repurchase program as of September 30, 2025[155]. - The company repurchased a total of 4,545,461 shares at an aggregate cost of $234 million, with $416 million remaining available for future repurchase under the program as of September 30, 2025[175]. - The company’s Board of Directors approved a new share repurchase authorization of up to $650 million from September 4, 2024, through September 4, 2027[175]. - During the three months ended September 30, 2025, the average price paid per share for repurchased shares was $60.31[176]. Risk Factors and Controls - The company has not identified any material changes to the risk factors disclosed in its 2024 Form 10-K during the nine months ended September 30, 2025[174]. - The company continues to evaluate additional risks and uncertainties that could materially affect its business and financial condition[174]. - There were no changes to the internal control over financial reporting that materially affected the company during the most recently completed fiscal quarter[172]. - As of September 30, 2025, the company concluded that its disclosure controls and procedures were effective[171]. Market Conditions - The company faces challenges from a declining real estate market, which constrains demand for home warranties[109]. - Inflation continues to impact labor, parts, and equipment costs, which may affect overall financial performance[109]. - Seasonal fluctuations significantly affect revenue, with 21% of revenue recognized in Q1, 29% in Q2, 29% in Q3, and 21% in Q4 of 2024[105].

Exhibit 99.1 HubSpot Reports Q3 2025 Results CAMBRIDGE, MA (November 5, 2025) — HubSpot, Inc. (NYSE: HUBS), the customer platform for scaling companies, today announced financial results for the third quarter ended September 30, 2025. Financial Highlights: Revenue Operating Income (Loss) Net Income Balance Sheet and Cash Flow Additional Recent Business Highlights Page | 1 ● Total revenue was $809.5 million, up 21% on an as-reported basis and 18% in constant currency compared to Q3'24. o Subscription revenue ...

Financial Performance - Net income for Q3 2025 was $116 million, or $0.28 per diluted share, compared to $51 million and $0.12 per diluted share in Q2 2025[4]. - Adjusted operating income for Q3 2025 was $17 million, or $0.04 per diluted share, down from $68 million and $0.16 per diluted share in Q2 2025[4]. - Total revenues for the three months ended September 30, 2025, were $1,935 million, an increase from $1,880 million in the same period of 2024, representing a growth of 2.9%[39]. - Net income available to Genworth Financial, Inc.'s common stockholders for Q3 2025 was $116 million, compared to $85 million in Q3 2024, reflecting a year-over-year increase of 36.5%[39]. - Adjusted operating income for Q3 2025 was $17 million, down from $48 million in Q3 2024, indicating a decline of 64.6%[41]. - Premiums collected in Q3 2025 amounted to $886 million, up from $874 million in Q3 2024, showing a growth of 1.4%[39]. - The company reported net investment income of $799 million for Q3 2025, compared to $777 million in Q3 2024, marking an increase of 2.8%[39]. - The loss from discontinued operations for Q3 2025 was $8 million, compared to a loss of $3 million in Q3 2024, indicating a deterioration in this segment[41]. - The basic earnings per share for net income available to common stockholders was $0.29 for Q3 2025, up from $0.20 in Q3 2024, reflecting a growth of 45%[41]. Capital Management - Genworth authorized a new $350 million share repurchase program and executed $76 million in share repurchases during the quarter[5]. - The company anticipates potential dividends and share repurchases as part of its future capital return strategy[34]. - A tax benefit of $27 million was recognized in the three months ended September 30, 2025, due to the release of a portion of the valuation allowance on deferred tax assets[17]. - Genworth's equity ownership, including accumulated other comprehensive income, was reported at $1,009 million as of September 30, 2025[9]. - The holding company cash and liquid assets totaled $254 million at the end of the quarter, including approximately $145 million for future obligations[20]. - As of September 30, 2025, Genworth's cash held for future obligations amounted to approximately $145 million[8]. Insurance Operations - The company delivered 950 matches with home care providers, achieving over 95% home care coverage for the aged 65-plus population in the U.S.[5]. - Long-term care insurance premiums increased to $597 million in Q3 2025, compared to $578 million in Q2 2025[12]. - Primary new insurance written by Enact was $14,048 million, up 6% from the prior quarter[7]. - The U.S. life insurance companies' RBC ratio was 303%, slightly down from 304% in the prior quarter[18]. - The Private Mortgage Insurer Eligibility Requirements (PMIERs) sufficiency ratio is calculated as available assets divided by required assets, indicating financial stability[10]. - The risk-based capital ratio for Genworth Life Insurance Company (GLIC) is based on company action level, ensuring regulatory compliance[6]. Strategic Initiatives - Management emphasizes the importance of statutory pre-tax earnings as a measure of capital adequacy, with combined statutory pre-tax earnings from principal U.S. life insurance companies being a key focus[33]. - The company is pursuing new lines of business and products through its CareScout services, indicating a strategic expansion into new markets[34]. - Genworth reported a net gain from operations before dividends and taxes for GLIC, GLAIC, and GLICNY, reflecting strong operational performance[12]. Investment and Financial Oversight - Net investment income for the quarter was $631 million, down from $634 million in the prior quarter but up from $614 million in the prior year[10]. - Net investment gains and losses were adjusted for noncontrolling interests, indicating careful financial oversight[15]. - Changes in fair value of market risk benefits were adjusted to exclude certain reserve changes, demonstrating risk management practices[16]. - Holding company cash and liquid assets are maintained in Genworth Holdings, Inc., supporting liquidity and operational needs[13]. - The company estimates a financial statement filing for the third quarter of 2025, reflecting ongoing financial management efforts[7].

FOR IMMEDIATE RELEASE Q2 Holdings, Inc. Announces Third Quarter 2025 Financial Results; Announces $150 million share repurchase authorization AUSTIN, Texas (November 5, 2025)—Q2 Holdings, Inc. (NYSE: QTWO), a leading provider of digital transformation solutions for financial services, today announced results for its third quarter ending September 30, 2025. GAAP Results for the Third Quarter 2025 Non-GAAP Results for the Third Quarter 2025 For a reconciliation of our GAAP to non-GAAP results, please see the ...

Exhibit 99.1 Solid Q1 execution positions Amcor to deliver strong earnings and free cash flow growth for FY26 Amcor CEO Peter Konieczny said, "I am pleased with how the legacy Amcor and Berry teams have come together as one to integrate and execute against our priorities. We're seeing strong and consistent validation from our customers, who are very receptive to our expanded offerings and innovation capabilities. We are now seeing the quality of the combined business as the global leader in consumer packagi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 1-39804 Exact name of registrant as specified in its charter: Texas Pacific Land Corporation State or other juris ...

Product Development and Approval - The Eversense E3 system, approved by the FDA in February 2022, offers a 180-day continuous glucose monitoring (CGM) solution, while the Eversense 365 system, approved in September 2024, extends this duration to 365 days[123][139]. - The mean absolute relative difference (MARD) for the Eversense 90 system was reported at 8.5% during a pivotal clinical trial, demonstrating its accuracy over a 90-day period[129]. - The ENHANCE pivotal study for Eversense 365 completed enrollment in the third quarter of 2023, supporting its FDA 510(k) submission approved on September 17, 2024[137][139]. - The FDA approved the Eversense E3 system with proprietary technology that doubles sensor life to six months, maintaining a MARD of 8.5%[136]. - The company began first-in-human testing for the Gemini product in July 2024, which is expected to enhance its product offerings for diabetes management[142]. - Eversense 365 was submitted for CE Mark approval in February 2025, with plans to launch in European markets in the first half of 2026 upon approval[145]. Market Access and Coverage - Approximately 300 million covered lives in the United States have access to Eversense systems due to positive insurance payor coverage decisions, including coverage from UnitedHealthcare effective July 1, 2023[126]. - Medicare coverage for Eversense E3 was expanded in February 2024 to include all insulin users and non-insulin users with a history of problematic hypoglycemia, increasing access for millions of Medicare patients[126]. - The company has entered into strategic partnerships and distribution agreements to promote Eversense systems, including a 2-in-1 glucose monitoring system called "Gemini" and a Bluetooth-enabled product variation[128]. - Eon Care Services, LLC and Eon Management Services, LLC were established to enhance patient access to Eversense systems, with an increase in insertions noted during the second and third quarters of 2025[140]. Financial Performance - Total revenue increased to $8.1 million for the three months ended September 30, 2025, compared to $4.3 million for the same period in 2024, representing a growth of 88.7%[160]. - Revenue from sales to Ascensia accounted for 48% of total revenue for the three months ended September 30, 2025, down from 78% in the same period of 2024[152]. - Revenue from consignment arrangements accounted for 46.5% of total revenue for the three months ended September 30, 2025, compared to 20.1% for the same period in 2024[153]. - Gross profit increased to $3.5 million for the three months ended September 30, 2025, with a gross margin of 42.8%, compared to a gross loss of $4.1 million and a margin of (95.0%) in the same period of 2024[161]. - Total revenue increased to $21.0 million for the nine months ended September 30, 2025, compared to $14.2 million for the same period in 2024, an increase of $6.8 million[167]. - Gross profit increased to $8.1 million for the nine months ended September 30, 2025, compared to a loss of $3.4 million for the same period in 2024, resulting in a gross margin of 38.5%[168]. Expenses and Losses - Research and development expenses decreased to $7.8 million for the three months ended September 30, 2025, down from $10.5 million in the same period of 2024, a reduction of 25.7%[162]. - Selling, general and administrative expenses rose to $15.3 million for the three months ended September 30, 2025, compared to $8.3 million in the same period of 2024, an increase of 84.3%[163]. - Research and development expenses decreased to $22.8 million for the nine months ended September 30, 2025, down from $31.8 million in 2024, a reduction of $9.0 million[169]. - Selling, general and administrative expenses increased to $32.7 million for the nine months ended September 30, 2025, compared to $25.4 million in 2024, an increase of $7.3 million[170]. - The company incurred a net loss of $48.3 million for the nine months ended September 30, 2025, compared to a net loss of $63.1 million in 2024, an improvement of $14.8 million[166]. Cash Flow and Financing - Net cash used in operating activities was $41.2 million for the nine months ended September 30, 2025, compared to $46.2 million for the same period in 2024, reflecting a decrease of 6.5%[186][187]. - Net cash used in investing activities increased significantly to $76.1 million for the nine months ended September 30, 2025, from $14.8 million in 2024[188][189]. - Net cash provided by financing activities was $77.1 million for the nine months ended September 30, 2025, a substantial increase from $12.8 million in 2024[190][191]. - The company entered into an at-the-market sales agreement with TD Securities for the sale of up to $100.0 million in common stock[173]. - The company completed a public offering of 5,000,000 shares at a price of $10.00 per share, raising gross proceeds of $57.5 million[176]. - The company had $72.3 million in net proceeds from a public offering and private placement during the nine months ended September 30, 2025[190]. Going Concern and Future Outlook - The company has determined that substantial doubt exists regarding its ability to continue as a going concern for the one-year period following the issuance of the financial statements[183]. - There is no assurance that the company will be successful in obtaining sufficient funding on acceptable terms, which could adversely affect its business prospects[183]. - The company plans to finance its cash needs through public or private debt and equity financings, collaborations, strategic alliances, and licensing arrangements[183]. - The company is negotiating the transfer of commercial operations related to Eversense from Ascensia back to itself, which may enhance revenue generation and market adoption[182].

Financial Performance - For the three months ended September 30, 2025, the company reported revenue of $3.721 billion, a decrease of 1% compared to the prior-year period[118]. - Net income for the same period was $68 million, an increase of $111 million from the prior-year period, reflecting improved operating efficiencies[118]. - For the six months ended September 30, 2025, revenue was $7.464 billion, also a decrease of 1% year-over-year[119]. - Adjusted EBITDA for the three months ended September 30, 2025, was $641 million, representing a 15% increase compared to the prior-year period[122]. Revenue Breakdown - United States revenue for the three months ended September 30, 2025, was $899 million, a decline of 6% year-over-year[130]. - Japan revenue for the three months ended September 30, 2025, was $581 million, a decrease of 4% compared to the prior-year quarter[131]. - Principal Markets revenue increased by 1% to $1.334 billion for the three months ended September 30, 2025[122]. - Strategic Markets revenue increased by 2% to $906 million for the same period[122]. Currency Impact - The company experienced a favorable currency exchange rate impact of three points on revenue performance for the three months ended September 30, 2025[118]. - Principal Markets revenue for Q3 2025 was $1.334 billion, a 1% increase year-over-year, with a favorable currency exchange impact of 4 points[133]. - Strategic Markets revenue for Q3 2025 was $906 million, a 2% increase year-over-year, also benefiting from a favorable currency exchange impact of 4 points[135]. Operational Efficiency - The company aims to drive operating efficiencies and higher margins on recent signings as part of its key initiatives[120]. - Adjusted EBITDA for Principal Markets in Q3 2025 increased by $23 million to $210 million, driven by operational efficiencies and higher margins[133]. - Adjusted EBITDA for Strategic Markets in Q3 2025 increased by $4 million to $142 million, attributed to key initiatives for operational efficiency[137]. Assets and Liabilities - Total assets increased by $792 million to $11.2 billion from March 31, 2025, primarily due to an increase in deferred costs[154]. - Total liabilities rose by $784 million to $9.9 billion, mainly due to an increase in other noncurrent liabilities related to a software agreement[155]. Cash Flow and Financing - Net cash provided by operating activities was $22 million in the six months ended September 30, 2025, down from $101 million in the prior-year period[158]. - Net cash used in financing activities totaled $310 million in the six months ended September 30, 2025, primarily due to share repurchases of $154 million[160]. - The company has sufficient liquidity with existing cash and cash equivalents and a revolving credit agreement to meet anticipated operating cash needs for at least the next twelve months[163]. Share Repurchase Program - The company repurchased 2.9 million shares at a cost of $89 million during the three months ended September 30, 2025, and 4.6 million shares for $154 million during the six months ended September 30, 2025[175]. - The Board of Directors approved an increase to the Share Repurchase Program, adding $400 million of repurchase capacity as of November 2025[175]. Signings and Contracts - Total signings for the three months ended September 30, 2025, were $2.8 billion, a decrease of 49% compared to the prior-year quarter, and for the six months ended September 30, 2025, signings were $6.0 billion, down 31% from $8.7 billion in the same period of 2024[162]. - The largest signing in Kyndryl's history, valued at $1.8 billion, occurred in the quarter ended September 30, 2024, impacting the current year's performance[162]. Debt and Credit Agreements - In October 2021, Kyndryl completed an offering of $2.4 billion in senior unsecured fixed-rate notes, with various maturities ranging from 2026 to 2041[164]. - A registered offering of $500 million in senior unsecured notes due 2034 was completed in February 2024, with net proceeds of $494 million[165]. - The company entered into a $3.15 billion multi-currency revolving credit agreement in October 2021, which was amended in March 2025 to extend the maturity to March 2030[167]. - As of September 30, 2025, there has been no drawdown on the revolving credit agreement, and the company is in compliance with its debt covenants[168]. Workforce and Charges - Workforce rebalancing charges for Q3 2025 were $19 million, with total expected cash outlays for the program around $80 million[147]. - The provision for income taxes for Q3 2025 was $30 million, compared to $38 million in Q3 2024, primarily related to foreign operations[151].

Revenue and Growth - Revenue for Q3 2025 was $179.5 million, an 11% increase year-over-year[6] - Contribution ex-TAC for Q3 2025 was $166.8 million, up 12% year-over-year, exceeding guidance of $161 to $165 million[6] - Contribution ex-TAC attributable to CTV was $75.8 million, an 18% increase year-over-year, exceeding guidance of $71 to $73 million[6] - Full-Year 2025 expectations for total Contribution ex-TAC are between $191 million and $196 million, representing growth of 6% to 9%[6] - Contribution ex-TAC attributable to CTV for Q4 2025 is expected to be between $87 million and $89 million, representing growth of 12% to 14%[6] - The company anticipates total Contribution ex-TAC growth above 10%, or mid-teens excluding political[6] - The company reported a total of $508,597 thousand in revenue for the nine months ended September 30, 2025, compared to $474,202 thousand for the same period in 2024, reflecting a growth of 7.3%[30] - Revenue for the nine months ended September 30, 2025, increased to $508,597,000, up 7.3% from $474,202,000 in the same period of 2024[37] Profitability - Net income for Q3 2025 was $20.1 million, compared to $5.2 million in Q3 2024, representing a 285% increase[8] - Adjusted EBITDA for Q3 2025 was $57.2 million, up 13% year-over-year, with a margin of 34%[6] - Adjusted EBITDA for the three months ended September 30, 2025, was influenced by revenue of $179,494 thousand, a 10.2% increase from $162,003 thousand in the same period of 2024[30] - Net income for the three months ended September 30, 2025, was $20,058 thousand, compared to $5,214 thousand for the same period in 2024, representing a significant increase[30] - Non-GAAP income for the nine months ended September 30, 2025, was $80,141,000, compared to $55,011,000 in the same period of 2024, reflecting a 45.6% increase[42] - Basic earnings per share for the three months ended September 30, 2025, was $0.14, compared to $0.04 for the same period in 2024[30] - Basic earnings per share for the nine months ended September 30, 2025, was $0.15, compared to a loss of $0.10 per share in the same period of 2024[36] - Non-GAAP earnings per share for the three months ended September 30, 2025, was $0.20, compared to $0.17 in the same period of 2024[44] Expenses and Liabilities - Total expenses for the three months ended September 30, 2025, were $154,453 thousand, an increase from $146,880 thousand in the same period of 2024[30] - Stock-based compensation expense for the three months ended September 30, 2025, was $18,044 thousand, slightly down from $18,670 thousand in the same period of 2024[31] - Total liabilities as of September 30, 2025, were $2,112,739 thousand, compared to $2,086,550 thousand as of December 31, 2024[28] Assets and Cash Flow - Total current assets as of September 30, 2025, were $1,725,514 thousand, up from $1,703,180 thousand as of December 31, 2024[28] - Cash and cash equivalents as of September 30, 2025, were $482,127 thousand, compared to $483,220 thousand as of December 31, 2024[28] - The company’s total assets as of September 30, 2025, were $2,920,693 thousand, an increase from $2,854,768 thousand as of December 31, 2024[28] - Cash provided by operating activities for the nine months ended September 30, 2025, was $107,711,000, down from $120,504,000 in the same period of 2024[34] - Net cash used in investing activities for the nine months ended September 30, 2025, was $63,741,000, compared to $40,669,000 in the same period of 2024, indicating increased investment[34] - Cash paid for interest decreased to $21,674,000 for the nine months ended September 30, 2025, from $28,748,000 in the same period of 2024, showing improved interest management[35] Shareholder Information - The weighted-average shares used to compute basic earnings per share increased to 143,009,000 for the three months ended September 30, 2025, from 141,270,000 in 2024[44] - The dilutive effect of weighted-average common stock options, RSUs, and PSUs was 10,105,000 for the three months ended September 30, 2025[44] - For the three months ended September 30, 2025, GAAP diluted earnings per share increased to $0.13 compared to $0.04 for the same period in 2024[44] Channel Performance - Contribution ex-TAC from CTV for the three months ended September 30, 2025, was $75,847,000, accounting for 45% of total contribution, compared to 43% in the same period of 2024[46] - Mobile channel contribution ex-TAC for the three months ended September 30, 2025, was $64,428,000, representing 40% of total contribution, consistent with the previous year[46] - Desktop channel contribution ex-TAC for the three months ended September 30, 2025, was $26,504,000, maintaining a 17% share of total contribution[46] - Total contribution ex-TAC for the nine months ended September 30, 2025, reached $474,583,000, a 11.2% increase from $426,744,000 in 2024[46] Strategic Initiatives - The acquisition of streamer.ai is expected to provide early benefits, particularly among SMB advertisers[5] - Adjusted EBITDA margin is expected to expand by approximately 180 basis points[6]